High proportion of T-cell systemic non-hodgkin lymphoma in HIV-infected patients in Lima, Peru

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 5, 2005, Pages 558-564

  Collins, Jaime A ^a   Hernández, Adrián V ^a,b   Hidalgo, José A ^a   Villena, Juan ^a   Sumire, Julia ^a   Delgado, Victor ^a   Salazar, Raúl ^a  

^a HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

AIDS; Epidemiology; HIV; Non Hodgkin lymphoma; Peru; T cell lymphoma

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; B CELL LYMPHOMA; BEHAVIOR; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENDER; GENERAL HOSPITAL; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PERU; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL; SURVIVAL RATE; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERU; PHENOTYPE;

EID: 27944489941     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000185135.54920.79     Document Type: Article

References (56)

1. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer. 2001;37:1188-1201.
2. International Collaboration on HIV and cancer. Highly active antiretroviral therapy and incidence of cancer in HIV-infected adults. J Natl Cancer Inst. 2000;92:1823-1829.
3. Mathews GV, Bower M, Mandalia S, et al. Changes in AIDS-related lymphoma since the introduction of HAART. Blood. 2000;96:2730-2734.
4. Mocroft A, Kalama C, Johnson AM, et al. AIDS across Europe, 1994-1998: the EuroSIDA study. Lancet. 2000;356:291-296.
5. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood. 2001;98:3406-3412.
6. Otieno MW, Banura C, Katongole E, et al. Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa. J Natl Cancer Inst. 2002;94:718-732.
7. Thomas JO. AIDS-associated cancer in sub-Saharan Africa. Semin Oncol. 2001;28:198-206.
8. Sparano JA. Clinical aspects and management of AIDS-related lymphoma. Eur J Cancer. 2001;37:1296-1305.
9. Roithmann S, Andrieu JM. Clinical and biological characteristics of malignant lymphomas in HIV-infected patients. Eur J Cancer. 1992;28A:1501-1508.
10. Tirelli U, Spina M, Vaccher E, et al. Clinical evaluation of 451 patients with HIV related non-Hodgkin's lymphoma: experience of the Italian Cooperative Group on AIDS and Tumors (GICAT). Leuk Lymphoma. 1995;20:91-96.
11. Sandler AS, Kaplan LD. Hematologic and oncologic aspects of HIV infection. Hematol Oncol Clin North Am. 1996;10:1111-1129.
12. Ribera JM. HIV-associated lymphomas [in Spanish]. Med Clin (Barc). 1999;113:349-356.
13. Levine AM. Acquired immunodeficiency syndromes-related lymphoma: clinical aspects. Semin Oncol. 2000;27:442-453.
14. Bower M. AIDS-related systemic non-Hodgkin's lymphoma. Br J Haematol. 2001;112:863-873.
15. Centers for Disease Control and Prevention. 1993 Revised CDC HIV classification system and expanded AIDS surveillance definition for adolescents and adults. MMWR. 1992;41:17.
16. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging. Cancer Res. 1971;31:1860-1861.
17. Jaffe ES, Harris NL, Steinb H, Vardiman JW. Pathology and genetics: neoplasms of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001:1-351.
18. Joint United Nations Program on HIV/AIDS (UNAIDS). Report on the Global AIDS Epidemic. Geneva: World Health Organization; 2004.
19. Peruvian Ministry of Health, General Office of Epidemiology. Situation of HIV/AIDS in Peru [in Spanish]. Monthly Epidemiological Bulletin. April 2005:1-2.
20. Oh M, Park SW, Kim HB, et al. Spectrum of opportunistic infections and malignancies in patients with HIV infection in South Korea. Clin Infect Dis. 1999;29:1524-1528.
21. Lowenthal DA, Straus DJ, Campbell SW, et al. AIDS-related lymphoid neoplasia. The Memorial Hospital Experience. Cancer. 1988;61:2325-2337.
22. Carbone A, Tirelli U, Vaccher E, et al. A clinicopathologic study of lymphoid neoplasias associated with HIV infection in Italy. Cancer. 1991; 68:842-845.
23. Rubio R, Pulido F, Pintado V, et al. AIDS-associated non-Hodgkin's lymphomas: multicenter clinical study of 77 cases [in Spanish]. Med Clin (Barc). 1995;104:481-486.
24. Armenian HK, Hoover DR, Rubb S, et al. Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Am J Epidemiol. 1996;143:374-379.
25. Pedersen C, Gerstoft J, Lundgren JD, et al. HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer. 1991;27:1416-1423.
26. Gerad L, Galicier L, Maillard A, et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr. 2002;30:478-484.
27. Hernández JA, Navarro JT, Ribera JM, et al. Primary gastrointestinal lymphomas in HIV-infected persons: study of 15 cases of a series of 76 patients with HIV-related NHL [in Spanish]. Med Clin (Barc). 1999;112:30-32.
28. Nasr SA, Brynes RK, Garrison CP, et al. Peripheral T-cell lymphoma in a patient with AIDS. Cancer. 1988;61:947-950.
29. Sternlieb J, Mintzer D, Kwa D, et al. Peripheral T-cell lymphoma in a patient with AIDS. Am J Med. 1988;85:445.
30. Lust JA, Banks PM, Hooper C, et al. T-cell non-Hodgkin's lymphoma in HIV 1-infected individuals. Am J Hematol. 1989;31:181-187.
31. Crane GA, Variakojis D, Rosen ST, et al. Cutaneous T-cell lymphoma in a patient with HIV infection. Arch Dermatol. 1991;127:989-994.
32. Bower M, Fife K. Current issues in the biology of AIDS-related lymphoma. HIV Med. 2001;2:141-145.
33. Levine AM, Seneviratne L, Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood. 1996;96:4084-4090.
34. Biggar RJ, Engels EA, Frisch M, et al. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr. 2001;26:371-376.
35. Beltran B, Malaga Zenteno J, Morales D. Clinico-epidemiological aspects of non-Hodgkin lymphoma at Rebagliati Hospital [abstract 45; in Spanish]. Presented at: XII National Congress of Internal Medicine; 2002; Peru.
36. Benites P, Chumpitaz R, Reátegui R, et al. Clinical, laboratory, and histological findings of extranodal non-Hodgkin lymphomas [in Spanish]. In: XVII Peruvian Congress on Cancerology Proceedings. Lima: Peruvian Cancer Society; 2001:45.
37. Collins JA, Reátegui R, Chumpitaz R, et al. Clinical, laboratory, and histological findings of nodal non-Hodgkin lymphomas [in Spanish]. In: XVII Peruvian Congress on Cancerology Proceedings. Lima: Peruvian Cancer Society; 2001:46.
38. Albújar P. Histological types and immunophenotype of nodal non-Hodgkin lymphomas [in Spanish]. Acta Cancerol (Lima). 1996;26:11-15.
39. Kim CW, Kim I, Ko YH, et al. Clinicopathologic and immunophenotypic study of non-Hodgkin lymphoma in Korea. J Korean Med Sci. 1992;7:193-198.
40. Izumo T, Maseki N, Mori S, et al. Practical utility of the revised European-American classification of lymphoid neoplasms for Japanese non-Hodgkin's lymphomas. Jpn J Cancer Res. 2000;91:351-360.
41. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
42. Parkin DM, Garcia-Giannoli H, Raphael M, et al. Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS. 2000;14:2929-2936.
43. Poiesz BJ, Papsidero LD, Ehrlich G, et al. Prevalence of HTLV-I associated T-cell lymphoma. Am J Hematol. 2001;66:32-38.
44. Lyons SF, Liebowitz DN. The roles of human viruses in the pathogenesis of lymphoma. Semin Oncol. 1998;25:461-475.
45. Zhou XG, Hamilton-Dutoit SJ, Yan QH, et al. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology. 1994;25:501-502.
46. Gabarre J, Raphael M, Lepage E, et al. HIV-related lymphoma: relation between clinical features and histologic subtypes. Am J Med. 2001;111:704-711.
47. Armitage J, Greer JP, Levine AM, et al. Peripheral T-cell lymphoma. Cancer. 1989;3:158-163.
48. Pinkus GS, O'Hara CJ, Said JW. Peripheral/post-thymic T-cell lymphomas: a spectrum of disease. Cancer. 1990;65:971-998.
49. Arzoo KK, Bu X, Espina B, et al. T-cell lymphoma in HIV-infected patients. J Acquir Immune Defic Syndr. 2004;36:1020-1027.
50. Diamond C, Taylor TH, Anton-Culvier H. Characteristics and survival of patients with non-Hodgkin's lymphoma with and without AIDS. Hematol Oncol. 2002;20:177-187.
51. Thiessard F, Morlat P, Marimoutou C, et al. Prognostic factor after non-Hodgkin lymphoma in patients infected with HIV. Cancer. 2000;88:1696-1702.
52. Antinori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to HAART. AIDS. 2001;15:1483-1491.
53. Tam HK, Luang ZF, Jacobson LP, et al. Effect of HAART on survival among HIV-infected men with Kaposi's sarcoma or non-Hodgkin lymphoma. Int J Cancer. 2002;98:916-998.
54. Spina M, Carbone A, Vaccher E, et al. Outcome in patients with non-Hodgkin lymphoma and with or without HIV infection. Clin Infect Dis. 2004;38:142-144.
55. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Group d'Etudes des lymphomas de l'Adulte (GELA). Blood. 1998;92:76-82.
56. Lippman SM, Miller TP, Spier CM. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood. 1998;72:436-441.